Ftse Mib
33.117,18
-0,21%
DAX
18.235,45
0,17%
S&P 500
5.460,48
-0,41%
NASDAQ
17.732,60
-0,71%
Bitcoin
60.103,15
-2,45%
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Elutia Inc (ELUT) Elutia Inc (ELUT) Notizie

ELUT

Elutia (ELUT)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:ELUT
DataOraFonteTitoloSimboloCompagnia
18/06/202422:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ELUTElutia Inc
17/06/202414:30Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:ELUTElutia Inc
17/06/202414:01GlobeNewswire Inc.Elutia Announces $13.26 Million Registered Direct OfferingNASDAQ:ELUTElutia Inc
17/06/202414:00GlobeNewswire Inc.Elutia Announces FDA Clearance of EluPro®: The First Antibiotic-Eluting BioEnvelope Designed to Protect Patients with Implantable Cardiac Pacemakers and DefibrillatorsNASDAQ:ELUTElutia Inc
10/06/202423:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ELUTElutia Inc
13/05/202423:01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ELUTElutia Inc
13/05/202414:00GlobeNewswire Inc.Elutia to Showcase BioEnvelope Product Line at Heart Rhythm 2024NASDAQ:ELUTElutia Inc
09/05/202422:05GlobeNewswire Inc.Elutia Announces First Quarter 2024 Results: SimpliDerm® Sales Increase 55%, CanGaroo®RM on Track for Second Quarter 2024 FDA ClearanceNASDAQ:ELUTElutia Inc
02/05/202422:05GlobeNewswire Inc.Elutia to Report First Quarter 2024 Financial Results on Thursday, May 9, 2024NASDAQ:ELUTElutia Inc
24/04/202422:05GlobeNewswire Inc.Elutia to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1NASDAQ:ELUTElutia Inc
11/03/202414:15Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:ELUTElutia Inc
07/03/202422:05GlobeNewswire Inc.Elutia Reports Fourth Quarter and Full Year 2023 Financial Results: Anticipates CanGarooRM® Clearance Decision in First Half of 2024NASDAQ:ELUTElutia Inc
22/02/202422:05GlobeNewswire Inc.Elutia to Report Fourth Quarter and Full Year 2023 Financial Results on Thursday, March 7, 2024NASDAQ:ELUTElutia Inc
14/02/202422:40Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:ELUTElutia Inc
25/01/202422:56Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:ELUTElutia Inc
10/01/202422:05GlobeNewswire Inc.Elutia Regains Compliance with Nasdaq Listing RequirementsNASDAQ:ELUTElutia Inc
09/01/202422:17Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:ELUTElutia Inc
18/12/202314:00GlobeNewswire Inc.Elutia Submits CanGarooRM® Antibiotic-Eluting Biomatrix for FDA ClearanceNASDAQ:ELUTElutia Inc
05/12/202306:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ELUTElutia Inc
20/11/202322:53Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:ELUTElutia Inc
13/11/202322:05GlobeNewswire Inc.Elutia Reports 26% Year-Over-Year Sales Growth of Proprietary Products and Strengthened Balance Sheet in Third Quarter 2023 Financial ResultsNASDAQ:ELUTElutia Inc
09/11/202314:30GlobeNewswire Inc.Elutia Completes Divestiture of Orthobiologics Business Unit for Cash Proceeds of Up to $35 MillionNASDAQ:ELUTElutia Inc
06/11/202322:05GlobeNewswire Inc.Elutia to Report Third Quarter 2023 Financial Results on Monday, November 13, 2023NASDAQ:ELUTElutia Inc
18/10/202314:00PR Newswire (US)SWK Holdings Highlights Recent Achievements and Provides Portfolio UpdateNASDAQ:ELUTElutia Inc
05/10/202316:24Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:ELUTElutia Inc
03/10/202317:05Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:ELUTElutia Inc
20/09/202314:30GlobeNewswire Inc.Elutia to Participate in a Panel Discussion at the Cantor Global Healthcare ConferenceNASDAQ:ELUTElutia Inc
19/09/202314:36GlobeNewswire Inc.Elutia Announces Private Placement for Proceeds Up to $26 MillionNASDAQ:ELUTElutia Inc
18/09/202322:08GlobeNewswire Inc.Elutia Announces Sale of Orthobiologics Business Unit for Cash Proceeds of Up to $35 MillionNASDAQ:ELUTElutia Inc
08/09/202314:30GlobeNewswire Inc.Elutia to Present at the H.C. Wainwright 25th Annual Global Investment ConferenceNASDAQ:ELUTElutia Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:ELUT

La tua Cronologia

BIT
UCG
Unicredit
BIT
STLAM
Stellantis NV
BIT
ISP
Intesa Sanpaolo
BIT
SPM
Saipem
BIT
ENI
Eni
BIT
BPE
Bper Banca
BIT
STMMI
ST Microelectronics
BIT
ENEL
Enel
BIT
TEN
Tenaris
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
CPR
Davide Campari
BIT
TRN
Terna Trasmissione Elett...
BIT
RACE
Ferrari NV
BIT
PRY
Prysmian
BIT
SRG
Snam
BIT
LDO
Leonardo
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network